133 related articles for article (PubMed ID: 1566493)
1. 15-Deoxyspergualin and mouse to rat heart retransplantation.
Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
Transplant Proc; 1992 Apr; 24(2):710-1. PubMed ID: 1566493
[No Abstract] [Full Text] [Related]
2. Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model.
Flores HC; Leventhal JR; Gruber SA; Figueroa J; Platt JL; Manivel C; Bach FH; Matas AJ; Bolman RM
Transplant Proc; 1992 Apr; 24(2):714. PubMed ID: 1566495
[No Abstract] [Full Text] [Related]
3. 15-Deoxyspergualin inhibits antibody production in mouse to rat heart transplantation.
Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
Transplant Proc; 1993 Feb; 25(1 Pt 1):778-80. PubMed ID: 8438478
[No Abstract] [Full Text] [Related]
4. The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival.
Pruitt SK; Halperin EC; Bollinger RR
Transplant Proc; 1991 Feb; 23(1 Pt 1):585-6. PubMed ID: 1990618
[No Abstract] [Full Text] [Related]
5. Therapy with 15-deoxyspergualin and total lymphoid irradiation blocks xenograft rejection and antibody formation after xenografting.
Marchman W; Araneda D; DeMasi R; Taylor D; Carobbi A; Larkin E; Alqaisi M; Thomas F
Transplant Proc; 1991 Feb; 23(1 Pt 1):210-1. PubMed ID: 1990515
[No Abstract] [Full Text] [Related]
6. Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
Gannedahl G; Karlsson-Parra A; Wallgren A; Roos-Engstrand E; Nilsson B; Tötterman TH; Tufveson G
Transplantation; 1994 Aug; 58(3):337-44. PubMed ID: 8053058
[TBL] [Abstract][Full Text] [Related]
7. Retransplantation after heart xenografting.
Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
Transplant Proc; 1992 Apr; 24(2):693. PubMed ID: 1566484
[No Abstract] [Full Text] [Related]
8. Effectiveness of combination therapy using cobra venom factor, splenectomy, and deoxyspergualin in guinea pig to rat cardiac xenografts.
Hayashi S; Ito M; Yokoyama I; Uchida K; Takagi H
Transplant Proc; 1993 Feb; 25(1 Pt 1):405-6. PubMed ID: 8438355
[No Abstract] [Full Text] [Related]
9. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival.
Wang J; Morris RE
Transplant Proc; 1991 Feb; 23(1 Pt 1):699-702. PubMed ID: 1990655
[No Abstract] [Full Text] [Related]
10. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model.
Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival of disparate cardiac xenografts: induction of tolerance and humoral accommodation.
Thomas F; Araneda D; Quarantillo P
Transplant Proc; 1994 Jun; 26(3):1220-3. PubMed ID: 8029894
[No Abstract] [Full Text] [Related]
12. Prolongation of concordant xenograft survival by a newly developed drug, FTY720.
Fujiwara I; Nakajima H; Matsuda T; Mizuta N; Yamagishi H; Oka T
Transplant Proc; 1999 Nov; 31(7):2831-3. PubMed ID: 10578306
[No Abstract] [Full Text] [Related]
13. Inhibition of natural antibody synthesis by cyclophosphamide or 15-deoxyspergualin fails to prevent xenograft rejection in the guinea pig-to-rat model.
Leventhal JR; Platt JL; Flores HC; Gruber SA; Matas AJ; Bolman RM
Transplant Proc; 1992 Apr; 24(2):551. PubMed ID: 1566426
[No Abstract] [Full Text] [Related]
14. Effect of 15-deoxyspergualin in islet xenograft rejection.
Yoshimura A; Nakajima Y; Kanehiro H; Nakano H
Transplant Proc; 1996 Jun; 28(3):1426-7. PubMed ID: 8658724
[No Abstract] [Full Text] [Related]
15. Concordant xenotransplantation--non-vascularized pancreatic islets are more difficult to regraft than the vascularized heart.
Bersztel A; Andersson A; Björkland A; Tufveson G; Johnsson C
Xenotransplantation; 2000 May; 7(2):118-28. PubMed ID: 10961296
[TBL] [Abstract][Full Text] [Related]
16. Synergism of splenectomy and immunosuppressive drugs in prolongation of cardiac xenograft survival.
Carobbi A; Araneda D; Quarantillo P; Thomas JM; Thomas FT
Transplant Proc; 1992 Apr; 24(2):527. PubMed ID: 1373543
[No Abstract] [Full Text] [Related]
17. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts.
Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF
Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689
[No Abstract] [Full Text] [Related]
18. Immunosuppressive mechanisms of 15-deoxyspergualin on heterotopic heart transplantation in rats.
Nakata S; Ito T; Shirakura R; Matsuda H; Fukuzawa M; Nakano S; Fukushima N; Kawashima Y
Transplant Proc; 1991 Feb; 23(1 Pt 1):864-5. PubMed ID: 1825004
[No Abstract] [Full Text] [Related]
19. Perioperative treatment with phosphatidic acid inhibitor (Lisofylline leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model.
Valdivia LA; Murase N; Rao AS; Rice G; Singer JW; Sun H; Todo S; Pan F; Subbotin V; Fung JJ; Starzl TE
Transplant Proc; 1996 Apr; 28(2):738-9. PubMed ID: 8623374
[No Abstract] [Full Text] [Related]
20. Successful retransplantation of mouse-to-rat cardiac xenografts under immunosuppressive monotherapy with cyclosporine.
Johnsson C; Andersson A; Bersztel A; Karlsson-Parra A; Gannedahl G; Tufveson G
Transplantation; 1997 Mar; 63(5):652-6. PubMed ID: 9075833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
